MW, H., NJ, S., S, D., KA, W., FK, G., TM, B., . . . CM, T. (2026). The bone marrow niche and hematopoietic system are distinctly remodeled by CD45-targeted astatine-211 radioimmunotherapy. Blood advances, 10(7), 2452. https://doi.org/10.1182/bloodadvances.2025017065
Chicago Style (17th ed.) CitationMW, Hagen, Setiawan NJ, Dexter S, Woodruff KA, Gaerlan FK, Billings TM, Orozco JJ, and Termini CM. "The Bone Marrow Niche and Hematopoietic System Are Distinctly Remodeled by CD45-targeted Astatine-211 Radioimmunotherapy." Blood Advances 10, no. 7 (2026): 2452. https://doi.org/10.1182/bloodadvances.2025017065.
MLA (9th ed.) CitationMW, Hagen, et al. "The Bone Marrow Niche and Hematopoietic System Are Distinctly Remodeled by CD45-targeted Astatine-211 Radioimmunotherapy." Blood Advances, vol. 10, no. 7, 2026, p. 2452, https://doi.org/10.1182/bloodadvances.2025017065.